Effectiveness of Spirometry as a Motivational Tool to Quit Smoking
- Conditions
- COPDSmoking Cessation
- Registration Number
- NCT01821885
- Lead Sponsor
- Basque Health Service
- Brief Summary
The aim of the study is to asses the efficacy of the spirometry and a minimal smoking cessation counselling intervention to quit smoking after a year in patients older than 40 years, smokers of more than 10 packs-year and without a chronic obstructive pulmonary disease (COPD) diagnosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 335
- Active smokers over 40 years and more than 10 pack-years
- Previous diagnosis of respiratory disease (asthma, COPD, interstitial lung disease) that cause alteration of spirometric pattern.
- Patients with limitations in performing spirometry
- Age greater than 80 years
- Institutionalized patients
- Patients with a life expectancy less than 1 year
- Spirometry in the past 2 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method The primary measure of results will be the differences in smoking cessation rates between intervention and control groups 12 months after been conducted the intervention In all patients who report smoking withdrawal, smoking cessation will be confirmed by air carbon monoxide concentration.
- Secondary Outcome Measures
Name Time Method Reduce the number of cigarettes among those who continue smoking 12 months after been conducted the intervention One secondary outcome will be to reduce the number of cigarettes. In all patients who continue smoking will be recorded the number of cigarettes smoked per day currently
Increase smoking abstinence rates in patients with COPD 12 months after been conducted the intervention Evaluate the differences in smoking cessation rates between patients with COPD and those without.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Basque health service
🇪🇸Vitoria-Gasteiz, Alava 45, Spain
Basque health service🇪🇸Vitoria-Gasteiz, Alava 45, Spain